ANKRD1 and bladder transitional cell carcinoma: As shown in Fig. 6, miR-10a-5p negatively regulated ANKRD1 expression in BLCA, BRCA, KIRC, MESO, and UCEC, miR-10b-5p negatively regulated ANKRD1 expression in BLCA, KIRC, LUSC, OV, PRAD, and SARC, miR-28-3p negatively regulated ANKRD1 expression in BLCA, and HNSC, miR-425-5p negatively regulated ANKRD1 expression in BLCA, COAD, HNSC, and READ.